PUBLISHER: Polaris Market Research | PRODUCT CODE: 1552479
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1552479
North America Veterinary Clinical Trials Market Size, Share, Trends, Industry Analysis Report: Information By Animal Type, By Intervention, By Indication, By End User, and By Country - Market Forecast, 2024 - 2032
The North America veterinary clinical trials market size is expected to reach USD 3,841.20 million by 2032, according to a new study by Polaris Market Research. The report "North America Veterinary Clinical Trials Market Size, Share, Trends, Industry Analysis Report, By Animal Type (Livestock Animal, Companion Animal, Other Animals); By Intervention; By Indication; By End Use; By Country; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The development of new drugs, vaccines, and biologics requires rigorous clinical trials to ensure safety and efficacy. Personalized treatments based on genetic profiling of animals boost the need for specialized clinical trials and drive the demand for the North America veterinary clinical trials market.
Also, increasing pet ownership and the humanization of pets have led to higher spending on veterinary healthcare, necessitating advanced treatments and clinical trials. Technological innovations, such as digital health tools and advanced diagnostic imaging, enhance the scope and efficiency of trials.
Regulatory support from bodies like the FDA and Health Canada, coupled with stringent animal welfare regulations, fosters a conducive environment for conducting clinical trials. Collaboration between pharmaceutical companies, research institutions, and veterinary clinics, along with public-private partnerships, accelerates research and development.
The growing prevalence of chronic and infectious diseases in animals drives the need for effective treatments and vaccines. Increased healthcare expenditure and significant investments in veterinary research further bolster the veterinary clinical trials market.
Furthermore, enhanced education and training programs for veterinarians improve the implementation and management of clinical trials. Additionally, growing awareness among pet owners about advanced veterinary care and the economic impact of maintaining livestock health contribute to the demand for veterinary clinical trials market.
North America Veterinary Clinical Trials Market Report Highlights
In 2023, the companion animal segment accounted for the largest market share due to a rise in pet ownership, driven by changing lifestyles, urbanization, and increased disposable income.
The pharmaceutical and biopharmaceutical companies segment accounted for the largest market share in 2023 due to their heavy investment in research and development to create innovative veterinary drugs, vaccines, and therapies.
The U.S. veterinary clinical trials market accounted for the largest market share in 2023 due to its highly developed regulatory framework, particularly through the FDA (Food and Drug Administration), which sets stringent standards for the approval of veterinary products.
The Nort America key market players include Argenta, Boehringer Ingelheim International GmbH., Charles River Laboratory, Clinvet, Cambridge Technologies, Knoell, IDEXX Laboratories, Inc., Labcorp Drug Development, Merck & Co., Inc., and Vivesto AB.
Polaris Market Research has segmented the North America veterinary clinical trials market report based on animal type, intervention, indication, end-user, and country:
Veterinary Clinical Trials, Animal Type Outlook (Revenue - USD Million, 2019 - 2032)
- Livestock Animal
- Companion Animal
- Other Animals
Veterinary Clinical Trials, Intervention Outlook (Revenue - USD Million, 2019 - 2032)
- Medicines
- Medical Device
- Others
Veterinary Clinical Trials, Indication Outlook (Revenue - USD Million, 2019 - 2032)
- Orthopedics
- Oncology
- Cardiology
- Ophthalmology
- Neurology
- Dermatology
- Internal Medicine
- Other Indication
Veterinary Clinical Trials, End-User Outlook (Revenue - USD Million, 2019 - 2032)
- Academics And Research Centers
- Pharmaceutical And Biopharmaceutical Companies
- Others
Veterinary Clinical Trials, Country Outlook (Revenue - USD Million, 2019 - 2032)
- North America
- US
- Canada
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. North America Veterinary Clinical Trials Market Insights
- 4.1. Veterinary Clinical Trials Market - Application Snapshot
- 4.2. Veterinary Clinical Trials Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rise in Technological Advancements Driving the Market Growth
- 4.2.1.2. Increasing Regulatory Support and Framework
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Regulatory Challenges
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Veterinary Clinical Trials Market Application Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. North America Veterinary Clinical Trials Market, by Animal Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. North America Veterinary Clinical Trials Market, by Animal Type, 2019-2032 (USD Million)
- 5.3. Companion Animal
- 5.3.1. North America Veterinary Clinical Trials Market, by Companion Animal, by Country, 2019-2032 (USD Million)
- 5.4. Livestock Animal
- 5.4.1. North America Veterinary Clinical Trials Market, by Livestock Animal, by Country, 2019-2032 (USD Million)
- 5.5. Other Animals
- 5.5.1. North America Veterinary Clinical Trials Market, by Others Animal, by Country, 2019-2032 (USD Million)
6. North America Veterinary Clinical Trials Market, by Intervention
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. North America Veterinary Clinical Trials Market, by Intervention, 2019-2032 (USD million)
- 6.3. Medicines
- 6.3.1. North America Veterinary Clinical Trials Market, by Medicines, by Country, 2019-2032 (USD million)
- 6.4. Medical Device
- 6.4.1. North America Veterinary Clinical Trials Market, by Medical Device, by Country, 2019-2032 (USD million)
- 6.5. Others
- 6.5.1. North America Veterinary Clinical Trials Market, by Others, by Country, 2019-2032 (USD million)
7. North America Veterinary Clinical Trials Market, by Indication
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. North America Veterinary Clinical Trials Market, by Indication, 2019-2032 (USD million)
- 7.3. Orthopedics
- 7.3.1. North America Veterinary Clinical Trials Market, by Orthopedics, By Country, 2019-2032 (USD million)
- 7.4. Oncology
- 7.4.1. North America Veterinary Clinical Trials Market, by Oncology, By Country, 2019-2032 (USD million)
- 7.5. Cardiology
- 7.5.1. North America Veterinary Clinical Trials Market, by Cardiology, By Country, 2019-2032 (USD million)
- 7.6. Ophthalmology
- 7.6.1. North America Veterinary Clinical Trials Market, by Ophthalmology, By Country, 2019-2032 (USD million)
- 7.7. Neurology
- 7.7.1. North America Veterinary Clinical Trials Market, by Neurology, By Country, 2019-2032 (USD million)
- 7.8. Dermatology
- 7.8.1. North America Veterinary Clinical Trials Market, by Dermatology, By Country, 2019-2032 (USD million)
- 7.9. Internal Medicine
- 7.9.1. North America Veterinary Clinical Trials Market, by Internal Medicine, By Country, 2019-2032 (USD million)
- 7.10. Other Indication
- 7.10.1. North America Veterinary Clinical Trials Market, by Other Indication, By Country, 2019-2032 (USD million)
8. North America Veterinary Clinical Trials Market, by End User
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. North America Veterinary Clinical Trials Market, by End User, 2019-2032 (USD million)
- 8.3. Academics And Research Centers
- 8.3.1. North America Veterinary Clinical Trials Market, by Academics and Research Centers, By Country, 2019-2032 (USD million)
- 8.4. Pharmaceutical And Biopharmaceutical Companies
- 8.4.1. North America Veterinary Clinical Trials Market, by Pharmaceutical and Biopharmaceutical Companies, By Country, 2019-2032 (USD million)
- 8.5. Others
- 8.5.1. North America Veterinary Clinical Trials Market, by Others, By Country, 2019-2032 (USD million)
9. North America Veterinary Clinical Trials Market, by Country
- 9.1. Key findings
- 9.2. Introduction
- 9.2.1. Veterinary Clinical Trials Market Assessment, By Country, 2019-2032 (USD million)
- 9.3. Veterinary Clinical Trials Market - North America
- 9.3.1. North America: Veterinary Clinical Trials Market, by Animal Type, 2019-2032 (USD million)
- 9.3.2. North America: Veterinary Clinical Trials Market, by Intervention, 2019-2032 (USD million)
- 9.3.3. North America: Veterinary Clinical Trials Market, by Indication, 2019-2032 (USD million)
- 9.3.4. North America: Veterinary Clinical Trials Market, by End User, 2019-2032 (USD million)
- 9.3.5. North America Veterinary Clinical Trials Market - U.S.
- 9.3.5.1. U.S.: Veterinary Clinical Trials Market, by Animal Type, 2019-2032 (USD million)
- 9.3.5.2. U.S.: Veterinary Clinical Trials Market, by Intervention, 2019-2032 (USD million)
- 9.3.5.3. U.S.: Veterinary Clinical Trials Market, by Indication, 2019-2032 (USD million)
- 9.3.5.4. U.S.: Veterinary Clinical Trials Market, by End User, 2019-2032 (USD million)
- 9.3.6. North America Veterinary Clinical Trials Market - Canada
- 9.3.6.1. Canada: Veterinary Clinical Trials Market, by Animal Type, 2019-2032 (USD million)
- 9.3.6.2. Canada.: Veterinary Clinical Trials Market, by Intervention, 2019-2032 (USD million)
- 9.3.6.3. Canada: Veterinary Clinical Trials Market, by Indication, 2019-2032 (USD million)
- 9.3.6.4. Canada: Veterinary Clinical Trials Market, by End User, 2019-2032 (USD million)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. Argenta
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Boehringer Ingelheim International GmbH
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Cambridge Technologies
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. Charles River Laboratory
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. Clinvet
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. IDEXX Laboratories, Inc.
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. Knoell
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. Labcorp Drug Development
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. Merck & Co., Inc.
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. Vivesto AB
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
List of Tables
- Table 1 North America Veterinary Clinical Trials Market, by Animal Type, 2019-2032 (USD million)
- Table 2 North America Veterinary Clinical Trials Market, by Intervention, 2019-2032 (USD million)
- Table 3 North America Veterinary Clinical Trials Market, by Indication, 2019-2032 (USD million)
- Table 4 North America Veterinary Clinical Trials Market, by End User, 2019-2032 (USD million)
- Table 5 Veterinary Clinical Trials Market Assessment, By Country, 2019-2032 (USD million)
- Table 6 U.S.: Veterinary Clinical Trials Market, by Animal Type, 2019-2032 (USD million)
- Table 7 U.S.: Veterinary Clinical Trials Market, by Intervention, 2019-2032 (USD million)
- Table 8 U.S.: Veterinary Clinical Trials Market, by Indication, 2019-2032 (USD million)
- Table 9 U.S.: Veterinary Clinical Trials Market, by End User, 2019-2032 (USD million)
- Table 10 Canada: Veterinary Clinical Trials Market, by Animal Type, 2019-2032 (USD million)
- Table 11 Canada: Veterinary Clinical Trials Market, by Intervention, 2019-2032 (USD million)
- Table 12 Canada: Veterinary Clinical Trials Market, by Indication, 2019-2032 (USD million)
- Table 13 Canada: Veterinary Clinical Trials Market, by End User, 2019-2032 (USD million)
List of Figures
- Figure 1. North America Veterinary Clinical Trials Market, 2019-2032 (USD million)
- Figure 2. Integrated Ecosystem
- Figure 3. Research Methodology: Top-Down & Bottom-Up Price
- Figure 4. Market by Country
- Figure 5. Porter's Five Forces
- Figure 6. Market by Animal Type
- Figure 7. North America Veterinary Clinical Trials Market, by Animal Type, 2023 & 2032 (USD million)
- Figure 8. Market by Intervention
- Figure 9. North America Veterinary Clinical Trials Market, by Intervention, 2023 & 2032 (USD million)
- Figure 10. Market by Indication
- Figure 11. North America Veterinary Clinical Trials Market, by Indication, 2023 & 2032 (USD million)
- Figure 12. Market by End User
- Figure 13. North America Veterinary Clinical Trials Market, by End User, 2023 & 2032 (USD million)
- Figure 12. North America Veterinary Clinical Trials Market Assessment, By Country, 2019-2032 (USD million)
- Figure 13. Strategic Analysis - North America Veterinary Clinical Trials Market
